Oxford University suspends AstraZeneca vaccine trial on children

Oxford University announced on Tuesday that it was suspending a trial of the Covid-19 vaccine that it developed with AstraZeneca on children and teenagers while British regulators investigate a potential blood clot link in adults, Euronews reported.

“Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial," the university said in a statement.

"Parents and children should continue to attend all scheduled visits and can contact the trial sites if they have any questions.”

The Medicines and Healthcare Regulatory Agency (MHRA) revealed on Saturday that seven people in the country had died from rare blood clots after getting the shot out of a total of 30 identified cases, while more than 18 million doses were administered in the country.

The British regulator said it wasn't clear if the shots are causing the clots.